Position in LLY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,396,461
+$480,581 QoQ
Shares Held
1,998
-4.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#2,334
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MITCHELL SINKLER & STARR/PA holds $19,003,477 across 8 Drug Manufacturers - General names. LLY ranks #4 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
42,391 | $5,447,243 | |
| 2 | JNJ |
Johnson & Johnson
|
21,432 | $5,443,085 | |
| 3 | ABBV |
AbbVie Inc.
|
13,417 | $3,376,253 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
1,998 | $2,396,461 | |
| 5 | AMGN |
Amgen Inc
|
2,295 | $831,065 | |
| 6 | PFE |
Pfizer Inc
|
27,742 | $668,027 | |
| 7 | NVS |
Novartis AG
|
3,193 | $500,406 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,917 | $340,937 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,396,461 | 1,998 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1,915,880 | 2,083 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2,281,545 | 2,123 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,852,564 | 2,428 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,895,037 | 2,431 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,983,009 | 2,401 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,847,396 | 2,393 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,716,292 | 3,066 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,414,648 | 2,667 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,957,803 | 3,802 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $8,254,730 | 14,161 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,542,508 | 8,457 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,059,425 | 2,259 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $863,014 | 2,513 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,210,930 | 3,310 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,058,971 | 3,275 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $1,199,651 | 3,700 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,059,569 | 3,700 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $757,395 | 2,742 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $772,169 | 3,342 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $767,055 | 3,342 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $624,352 | 3,342 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $699,335 | 4,142 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $613,098 | 4,142 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $936,154 | 5,702 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $790,981 | 5,702 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||